Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Nectar Lifesciences Ltd

NSE: NECLIFE · BSE: 532649 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹10.59
Market cap
₹237.5 Cr
Revenue (annual)
₹0.00 Cr
Net profit (annual)
₹-292.9 Cr
P/E (TTM)
-1.0×Sector 47.3×
Promoter holding
51.84%+0.00% QoQ
FII holding
0.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:00 IST BSE
Business Update

Nectar Lifesciences Business Update

Nectar LifeSciences Ltd filed its shareholding pattern as per Regulation 31(1)(b), detailing promoter and public holdings as of June 30, 2026. No monetary transaction disclosed.

13:20 IST BSE
Business Update

Nectar Lifesciences Business Update

Nectar Lifesciences Ltd launched its second 100-day 'Saksham Niveshak' campaign from April 1 to July 9, 2026. The initiative assists shareholders in updating KYC details and claiming unpaid dividends to prevent their transfer to the IEPF Authority. Investors are urged to contact KFin Technologies to safeguard their entitlements.

Execution
April 01, 2026, to July 09, 2026